By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
抗肿瘤类药物1.44B60.73%
技术授权收入904.04M38.07%
Research and development services26.34M1.11%
Testing service2.16M0.09%
By Industry
Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry2.37B99.91%
Other business2.16M0.09%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory1.44B60.60%
Overseas935.79M39.40%
